| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 39.686 | 43.100 | 23.729 | 32.330 | 61.570 | 59.632 | 60.739 | 59.645 | 8.147 |
| Total Income - EUR | - | 39.712 | 43.101 | 23.730 | 32.330 | 61.570 | 59.523 | 60.739 | 59.645 | 8.147 |
| Total Expenses - EUR | - | 17.262 | 23.191 | 14.541 | 13.399 | 26.329 | 27.970 | 29.416 | 57.627 | 16.694 |
| Gross Profit/Loss - EUR | - | 22.450 | 19.910 | 9.189 | 18.931 | 35.241 | 31.553 | 31.323 | 2.018 | -8.547 |
| Net Profit/Loss - EUR | - | 21.259 | 18.617 | 8.477 | 17.961 | 33.502 | 29.799 | 30.144 | 1.421 | -8.547 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nova Nano Implants Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 28.087 | 20.965 | 12.178 | 24.890 | 34.644 | 29.929 | 30.838 | 8.222 | 16.426 |
| Inventories | - | 7.504 | 8.294 | 1.698 | 1.865 | 5.210 | 7.376 | 9.026 | 3.257 | 10.483 |
| Receivables | - | 17.606 | 8.464 | 5.414 | 9.539 | 21.604 | 19.210 | 12.862 | 4.374 | 4.350 |
| Cash | - | 2.977 | 4.207 | 5.067 | 13.486 | 7.830 | 3.343 | 8.950 | 590 | 1.593 |
| Shareholders Funds | - | 21.303 | 18.669 | 8.529 | 18.012 | 33.551 | 29.848 | 30.192 | 1.470 | -7.085 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.800 | 2.296 | 3.649 | 6.879 | 1.092 | 81 | 646 | 6.752 | 23.511 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Nova Nano Implants Srl